TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
+40.53%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$277M
AUM Growth
+$277M
(+48%)
Cap. Flow
+$44.4M
Cap. Flow
% of AUM
16.06%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
3
Reduced
–
Closed
1
Top Buys
| 1 |
Heron Therapeutics
HRTX
|
$36.9M |
| 2 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$7.44M |
| 3 |
Cyclacel Pharmaceuticals
CYCC
|
$736K |
Top Sells
| 1 |
ATYR
aTyr Pharma
ATYR
|
$601K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Heron Therapeutics
HRTX
$207M
| $130M | 46.92% | 8,654,914 +2,457,716 | +40% | +$36.9M |
|
|
LJPC
2
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $103M | 37.12% | 3,440,419 +249,254 | +8% | +$7.44M |
|
|
RXDX
3
DELISTED
Ignyta, Inc.
RXDX
| $34.2M | 12.35% | 3,972,800 | – | – |
|
4
BioMarin Pharmaceuticals
BMRN
$11.2B
| $7.92M | 2.86% | 90,215 | – | – |
|
|
5
Cyclacel Pharmaceuticals
CYCC
$18.4M
| $2.06M | 0.74% | 559,900 +200,000 | +56% | +$736K |
|
|
ATYR
6
aTyr Pharma
ATYR
$527M
| – | – | -279,425 | Closed | -$601K |
|